These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 408419)

  • 21. Abrogation of anti-Pichinde virus cytotoxic T cell memory by cyclophosphamide and restoration by coinfection or interleukin 2.
    Walker CM; Paetkau V; Rawls WE; Rosenthal KL
    J Immunol; 1985 Aug; 135(2):1401-7. PubMed ID: 2989365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of treatment with IL-2 receptor specific monoclonal antibody in mice. Inhibition of cytotoxic T cell responses but not of T help.
    Leist TP; Kohler M; Eppler M; Zinkernagel RM
    J Immunol; 1989 Jul; 143(2):628-32. PubMed ID: 2544648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Entry of antivirally active T lymphocytes into the thymus of virus-infected mice.
    Gossmann J; Löhler J; Lehmann-Grube F
    J Immunol; 1991 Jan; 146(1):293-7. PubMed ID: 1898603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA; Ahmed R; Oldstone MB
    J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capacity of sensitized thymus-derived lymphocytes to induce fatal lymphocytic choriomeningitis is restricted by the H-2 gene complex.
    Doherty PC; Zinernagel RM
    J Immunol; 1975 Jan; 114(1 Pt 1):30-3. PubMed ID: 1078677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficiency and effectiveness of cloned virus-specific cytotoxic T lymphocytes in vivo.
    Klavinskis LS; Tishon A; Oldstone MB
    J Immunol; 1989 Sep; 143(6):2013-6. PubMed ID: 2476492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung.
    Chen HD; Fraire AE; Joris I; Brehm MA; Welsh RM; Selin LK
    Nat Immunol; 2001 Nov; 2(11):1067-76. PubMed ID: 11668342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel approach to visualize polyclonal virus-specific CD8 T cells in vivo.
    Zimmermann C; Pircher H
    J Immunol; 1999 May; 162(9):5178-82. PubMed ID: 10227990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low responsiveness to Dk or Db plus vaccinia virus or to Kk plus lymphocytic choriomeningitis virus assessed by availability of D or K products.
    Zinkernagel RM; Callahan GN
    Tissue Antigens; 1981 May; 17(5):507-17. PubMed ID: 6977890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired generation of anti-viral cytotoxicity against lymphocytic choriomeningitis and vaccinia virus in mice treated with CD4-specific monoclonal antibody.
    Leist TP; Kohler M; Zinkernagel RM
    Scand J Immunol; 1989 Dec; 30(6):679-86. PubMed ID: 2532394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cells that express viral antigens but lack H-2 determinants are not lysed by immune thymus-derived lymphocytes but are lysed by other antiviral immune attack mechanisms.
    Zinkernagel RM; Oldstone MB
    Proc Natl Acad Sci U S A; 1976 Oct; 73(10):3666-70. PubMed ID: 1086476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune responses to LCM virus infection in vivo and in vitro. Mechanisms of immune-mediated disease.
    Cole GA; Johnson ED
    Bull World Health Organ; 1975; 52(4-6):465-70. PubMed ID: 1085206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. H-2 compatibility requirement for virus-specific T-cell-mediated cytolysis. Evaluation of the role of H-2I region and non-H-2 genes in regulating immune response.
    Zinkernagel RM; Dunlop MB; Blanden RV; Doherty PC; Shreffler DC
    J Exp Med; 1976 Aug; 144(2):519-32. PubMed ID: 1085331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphohemopoietic origin of the immunogenic, virus-antigen-presenting cells triggering anti-viral T-cell responses.
    Zinkernagel RM; Kreeb G; Althage A
    Clin Immunol Immunopathol; 1980 Mar; 15(3):565-76. PubMed ID: 6966204
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of viruses on immune response.
    Allison AC; Virelizier JL
    Adv Nephrol Necker Hosp; 1975; 5():115-33. PubMed ID: 171931
    [No Abstract]   [Full Text] [Related]  

  • 36. Peritoneal macrophages as target cells for measuring virus-specific T cell mediated cytotoxicity in vitro.
    Zinkernagel RM; Doherty PC
    J Immunol Methods; 1975 Sep; 8(3):263-6. PubMed ID: 52680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. H-2 compatibility requirement for virus-specific T-cell-mediated cytolysis. The H-2K structure involved is coded by a single cistron defined by H-2Kb mutant mice.
    Zinkernagel RM
    J Exp Med; 1976 Feb; 143(2):437-43. PubMed ID: 1082490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytes.
    Perrin LH; Zinkernagel RM; Oldstone MB
    J Exp Med; 1977 Oct; 146(4):949-69. PubMed ID: 302316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. H-2 restriction of virus-specific cytotoxicity across the H-2 barrier. Separate effector T-cell specificities are associated with self-H-2 and with the tolerated allogeneic H-2 in chimeras.
    Zinkernagel RM
    J Exp Med; 1976 Oct; 144(4):933-45. PubMed ID: 62016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune response against vaccinia virus in rhesus monkeys: no evidence for primary MHC-restricted cytolytic T cells.
    Stitz L; Zinkernagel R; Balch CM; Bolhuis RL; Balner H
    Exp Cell Biol; 1984; 52(4):237-50. PubMed ID: 6610578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.